ENST00000356341:c.*611T>A

Variant names:

• chr11-77322663-A-T
• rs2844337
• NM_002576.5:c.*611T>A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2 BP4_Strong

The ENST00000356341.8(PAK1):​c.*611T>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency:
  • Genomes: not found (cov: 31)
  • Exomes 𝑓: 0.0 (0 hom.)
  • Failed GnomAD Quality Control
• Consequence: PAK1 ENST00000356341.8 3_prime_UTR
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 0.204
• Publications: 0 publications found

Genes affected

PAK1 (HGNC:8590): (p21 (RAC1) activated kinase 1) This gene encodes a family member of serine/threonine p21-activating kinases, known as PAK proteins. These proteins are critical effectors that link RhoGTPases to cytoskeleton reorganization and nuclear signaling, and they serve as targets for the small GTP binding proteins Cdc42 and Rac. This specific family member regulates cell motility and morphology. Mutations in this gene have been associated with macrocephaly, seizures, and speech delay. Overexpression of this gene is also reported in many cancer types, and particularly in breast cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2020]

PAK1 Gene-Disease associations (from GenCC):

• intellectual developmental disorder with macrocephaly, seizures, and speech delay

  Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P

ACMG classification

Our verdict: Likely_benign. The variant received -2 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.48).

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000356341.8. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	PAK1	NM_002576.5	MANE Select	c.*611T>A		3_prime_UTR	Exon 15 of 15	NP_002567.3
	PAK1	NM_001128620.2		c.*636T>A		3_prime_UTR	Exon 16 of 16	NP_001122092.1	Q13153-2
	PAK1	NM_001376268.1		c.*636T>A		3_prime_UTR	Exon 16 of 16	NP_001363197.1	Q13153-2

Ensembl Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	PAK1	ENST00000356341.8	TSL:1 MANE Select	c.*611T>A		3_prime_UTR	Exon 15 of 15	ENSP00000348696.4	Q13153-1
	PAK1	ENST00000873292.1		c.*611T>A		3_prime_UTR	Exon 15 of 15	ENSP00000543351.1
	PAK1	ENST00000873293.1		c.*611T>A		3_prime_UTR	Exon 15 of 15	ENSP00000543352.1

Frequencies

GnomAD3 genomes Cov.: 31

GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0 AN: 90552 Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0 AN XY: 44900

African (AFR) AF: 0.00 AC: 0 AN: 3028

American (AMR) AF: 0.00 AC: 0 AN: 5014

Ashkenazi Jewish (ASJ) AF: 0.00 AC: 0 AN: 4122

East Asian (EAS) AF: 0.00 AC: 0 AN: 10380

South Asian (SAS) AF: 0.00 AC: 0 AN: 5638

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 1782

Middle Eastern (MID) AF: 0.00 AC: 0 AN: 422

European-Non Finnish (NFE) AF: 0.00 AC: 0 AN: 54176

Other (OTH) AF: 0.00 AC: 0 AN: 5990

GnomAD4 genome Cov.: 31

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.48
CADD	Benign	12
DANN	Benign	0.83
PhyloP100		0.20

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs2844337; hg19: chr11-77033708;